Novartis Ag NVS
NYSE NVS
$158.86 +2.62 (+1.68%)
As of: Aug 21, 2026 · 3:59 PM EDT

Novartis Ag (NVS) EBITDA Margin (QoQ) (2009 - 2023)

Novartis Ag (NVS) EBITDA Margin (QoQ) (2009 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Sanofi 55.07 Bn 47.69 Bn 10.79 Bn

Historic Data

Download Data
DateValue
Jun 30, 2023 -154.34 Mn
Mar 31, 2023 154.33 Mn
Dec 31, 2022 -16,585.00
Sep 30, 2022 26,774.00
Jun 30, 2022 -1.32 Bn
Mar 31, 2022 1.32 Bn
Dec 31, 2021 231,312.00
Sep 30, 2021 -229,248.00
Jun 30, 2021 -498.24 Mn
Mar 31, 2021 498.24 Mn
Dec 31, 2020 -756.33 Mn
Sep 30, 2020 756.33 Mn
Jun 30, 2020 3,956.00
Jun 30, 2019 -9,353.00
Mar 31, 2019 -68,646.00
Dec 31, 2018 23,989.00
Sep 30, 2018 54,134.00
Jun 30, 2018 -17,152.00
Mar 31, 2018 18,846.00
Dec 31, 2017 446.00